{"id":"staccato-alprazolam","safety":{"commonSideEffects":[{"rate":null,"effect":"Sedation"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Respiratory depression"},{"rate":null,"effect":"Dependence potential"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Alprazolam is a benzodiazepine that potentiates the effect of the inhibitory neurotransmitter GABA by binding to GABA-A receptors, increasing chloride ion influx and hyperpolarizing neurons. The Staccato delivery system uses a proprietary pulmonary inhalation technology to achieve rapid systemic absorption through the lungs, enabling faster onset of action compared to oral formulations. This rapid onset is intended to provide faster symptom relief in acute anxiety or panic situations.","oneSentence":"Staccato alprazolam is a rapidly-absorbed inhaled formulation of alprazolam that binds to GABA-A receptors in the central nervous system to enhance inhibitory neurotransmission.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:36:07.236Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute anxiety or panic episodes (Phase 3 development)"}]},"trialDetails":[{"nctId":"NCT05077904","phase":"PHASE3","title":"A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures","status":"RECRUITING","sponsor":"UCB Biopharma SRL","startDate":"2021-12-07","conditions":"Stereotypical Prolonged Seizures","enrollment":350},{"nctId":"NCT05076617","phase":"PHASE3","title":"A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures","status":"ENROLLING_BY_INVITATION","sponsor":"UCB Biopharma SRL","startDate":"2022-02-03","conditions":"Stereotypical Prolonged Seizures","enrollment":300},{"nctId":"NCT07020988","phase":"PHASE1","title":"A Study to Assess the Time to Onset of Action of Staccato Alprazolam Versus Midazolam and Diazepam in Healthy Participants","status":"COMPLETED","sponsor":"UCB Biopharma SRL","startDate":"2025-06-12","conditions":"Healthy Participants","enrollment":55},{"nctId":"NCT05626439","phase":"PHASE1","title":"A Relative Bioavailability Study of Staccato Alprazolam Versus Oral Alprazolam in Healthy Study Participants","status":"COMPLETED","sponsor":"UCB Biopharma SRL","startDate":"2022-12-28","conditions":"Healthy Participants","enrollment":21},{"nctId":"NCT04802746","phase":"PHASE1","title":"A Study to Assess the Pulmonary Safety of Staccato Alprazolam in Healthy Study Participants and in Study Participants With Mild Asthma","status":"COMPLETED","sponsor":"UCB Biopharma SRL","startDate":"2021-03-09","conditions":"Healthy Study Participants, Participants With Mild Asthma","enrollment":78},{"nctId":"NCT04857307","phase":"PHASE1","title":"A Study to Assess the Pharmacokinetics (PK) and Safety of Staccato Alprazolam in Adolescent Study Participants With Epilepsy","status":"COMPLETED","sponsor":"UCB Biopharma SRL","startDate":"2021-04-28","conditions":"Epilepsy","enrollment":14},{"nctId":"NCT03516305","phase":"PHASE1","title":"Pharmacokinetic Study Evaluating Staccato® Alprazolam 1 mg Inhaler in Smokers Versus Non-Smokers","status":"COMPLETED","sponsor":"Engage Therapeutics, Inc.","startDate":"2018-04-06","conditions":"Healthy","enrollment":36},{"nctId":"NCT02351115","phase":"PHASE2","title":"Staccato Alprazolam and Photoparoxysmal Response","status":"COMPLETED","sponsor":"Alexza Pharmaceuticals, Inc.","startDate":"2015-01","conditions":"Epilepsy","enrollment":5},{"nctId":"NCT04782388","phase":"PHASE1","title":"Study to Assess the Safety, Tolerability, And Pharmacokinetics of Staccato Alprazolam in Healthy Japanese, Chinese, and Caucasian Participants","status":"COMPLETED","sponsor":"UCB Biopharma SRL","startDate":"2021-03-04","conditions":"Healthy Study Participants","enrollment":30},{"nctId":"NCT03478982","phase":"PHASE2","title":"Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern","status":"COMPLETED","sponsor":"Engage Therapeutics, Inc.","startDate":"2018-03-16","conditions":"Epilepsy","enrollment":156},{"nctId":"NCT00603980","phase":"PHASE1","title":"Staccato Alprazolam Abuse Liability","status":"COMPLETED","sponsor":"Alexza Pharmaceuticals, Inc.","startDate":"2008-01","conditions":"Abuse Liability of Staccato Alprazolam","enrollment":31},{"nctId":"NCT00477451","phase":"PHASE2","title":"Staccato Alprazolam in Panic Attack","status":"COMPLETED","sponsor":"Alexza Pharmaceuticals, Inc.","startDate":"2007-05","conditions":"Treatment of Induced Panic Attack","enrollment":49},{"nctId":"NCT00444522","phase":"PHASE1","title":"Staccato Alprazolam Single Dose PK","status":"COMPLETED","sponsor":"Alexza Pharmaceuticals, Inc.","startDate":"2005-06","conditions":"Healthy","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["UCB7538","STAP-001"],"phase":"phase_3","status":"active","brandName":"Staccato alprazolam","genericName":"Staccato alprazolam","companyName":"UCB Biopharma SRL","companyId":"ucb-biopharma-srl","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Staccato alprazolam is a small molecule that acts as a positive allosteric modulator of the GABA-A receptor, an anion channel. It has been studied in clinical trials for conditions such as epilepsy, mild asthma, and stereotypical prolonged seizures, with a focus on its efficacy in predictable seizure patterns.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}